NCT00428454View on ClinicalTrials.gov

Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions

PHASE3CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

June 30, 2015

Conditions
Coronary Artery DiseaseCoronary DiseaseCoronary Stenosis
Interventions
DEVICE

sirolimus-eluting stent, zotarolimus-eluting stent

PCI in chronically occluded coronary artery

Trial Locations (5)

2020

AZ Middelheim, Antwerp

1105AZ

AMC, Amsterdam

5602ZA

Catharina Ziekenhuis, Eindhoven

1090HM

Onze Lieve Vrouwe Gasthuis, Amsterdam

3435CM

St Antonius Hospital, Nieuwegein

Sponsors

Collaborators (1)

Cordis Corporation
All Listed Sponsors
collaborator

Cordis Corporation

INDUSTRY

lead

R&D Cardiologie

OTHER

NCT00428454 - Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions | Biotech Hunter | Biotech Hunter